Pharmafile Logo
Pharmafocus logo
Advanced Search
Project EVO

Digital software shows benefit in ADHD trial

October 30, 2015
Medical Communications ADHD, Akili, PureTech Health, attention deficit hyperactivity disorder, digital tech

A pilot study of a digital health technology designed to improve symptoms of attention deficit hyperactivity disorder (ADHD) in children …

News
sanofi_logo_vertical_2011_4colors-web

Sanofi recalls allergy injection pens

October 29, 2015
Manufacturing and Production Allerject, Sanofi, anaphylaxis

Sanofi has halted manufacturing and is recalling its Allerject auto-injectors following a blunder involving incorrect dosages. The voluntary recall involves …

News
faysal_kamoua

Alvogen appoints Faysal Kalmoua as EVP of portfolio

October 29, 2015
Medical Communications Alvogen, Faysal Kalmoua

Alvogen has announced the appointment of Faysal Kalmoua as its new executive vice president of portfolio.Kalmoua joins Alvogen with an …

Appointment
Constella

Allergan acquires rights to pioneering IBS treatment from Almirall

October 29, 2015
Medical Communications, Sales and Marketing Allergan, Constella, IBS, linaclotide

Allergan and its commercialisation partner Ironwood Pharmaceuticals have announced that Allergan has acquired the rights to Constella.The companies have acquired …

News
Coins

ANALYSIS: The challenges of forecasting biosimilar sales across Europe

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts

The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …

Feature
Yervoy

FDA approves Bristol-Myers Squibb’s skin cancer drug

October 29, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, Yervoy, ipilumumab, melanoma

The FDA has recommended Bristol-Myers Squibb’s cancer drug Yervoy (ipilimumab) for the adjuvant treatment of patients with melanoma. The drug, …

News
novo_nordisk

Novo Nordisk posts strong nine-month results

October 29, 2015
Sales and Marketing Novo Nordisk, insulin

Novo Nordisk has exceeded market expectations in its nine-month financial results, reporting a 51% increase in operating profit and 33% …

News

Bayer posts strong earnings growth

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing

Sales across the Bayer group rose by 1.9% in the third quarter of 2015 to €11 billion, according the company’s …

News
novartis

Novartis launches new hypertension program in Ghana

October 29, 2015
Research and Development

The Novartis Foundation and its partners have begun screening patients in a Community-based Hypertension Improvement Project (ComHIP) in Ghana in …

News
allergan_pfizer_logos

Pfizer in ‘friendly’ merger talks with Allergan

October 29, 2015
Sales and Marketing Actavis, Allergan, Pfizer, Teva

Pfizer is in talks with Allergan over what could be the largest takeover deal in an already record-breaking year, it …

News
jose_joe_almeida

Baxter names José Almeida chairman and chief executive

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Joe Almeida, José Almeida, baxter

Baxter has named José (Joe) Almeida as the company’s new chairman and chief executive from January 1, 2016. Almeida will …

Appointment
jane_osbourn_lg

Dr Jane Osbourn to join BIA board as chair

October 28, 2015

Dr Jane Osbourn, the vice president of research and development at MedImmune, will be the new chair of the BIA …

Appointment
imlygic_amgen

FDA approves first-in-class Amgen melanoma drug

October 28, 2015
Research and Development, Sales and Marketing Amgen, Imlygic, melonoma

The US Food and Drug Administration (FDA) has approved Amgen’s Imlygic for the treatment of melanoma lesions in the skin …

News
Jinarc

Otsuka kidney drug earns first NICE nod

October 28, 2015
Research and Development, Sales and Marketing NHS, NICE, jinarc, kidney disease, tolvaptan

NICE has released final guidance recommending Otsuka’s Jinarc, the first-ever treatment shown to slow progression of life-threatening Autosomal Dominant Polycystic …

News
Merck image

Sales up at MSD while Keytruda hits survival target in late-stage trial

October 28, 2015
Research and Development, Sales and Marketing MSD, Merck, financial results, keytruda, pembrolizumab

Worldwide sales at MSD were $10.1 billion in the third quarter of 2015, a 4% increase after accounting for the …

News
Sativex

Otsuka, GW announce Sativex fails in Phase III cancer pain trials

October 28, 2015
Research and Development, Sales and Marketing Cancer, GX Pharmaceuticals, Otsuka, Sativex, cancer pain, palliative care, phase III, phase III failure

Otsuka and GW Pharmaceuticals cannabis-based drug Sativex failed to show superiority over placebo in two Phase III trials.The studies were …

News
BGMA D-G Warwick Smith

OPINION: ‘More work remains if biosimilars are to fulfil their potential’

October 27, 2015
Manufacturing and Production, Research and Development, Sales and Marketing British Generic Manufacturers Association, NHS, bgma, biosimilars, generics, patent cliff, patents

Despite having a mature generics market which fulfils more than three-quarters of all prescriptions in the UK, and as a …

Feature
George Freeman

Pharma reaction to the Government’s AAR review

October 27, 2015
Manufacturing and Production, Research and Development Accelerated Access Review

The long-awaited interim report on the Government’s Accelerated Access Review has been published.The Government department overseeing the report, the Office …

News
Shire image

New Phase III data puts Shire’s lifitegrast back on track for 2016 launch

October 27, 2015
Research and Development Shire, dry eye disease, lifitegrast

Shire shares rose 6% today as the company reported new positive Phase III trial data for lifitegrast in the treatment …

News
Europe flag

EMA launches scheme to prioritise medicines access for patients

October 27, 2015
Manufacturing and Production EMA, European Medicines Agency, medicines access

The EMA has launched a public consultation on a scheme which aims to enable access to more medicines.The PRIME scheme …

News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026